Literature DB >> 22929218

Surgical decortication as the first-line treatment for pleural empyema.

Jung Ar Shin1, Yoon Soo Chang1, Tae Hoon Kim2, Seok Jin Haam3, Hyung Jung Kim1, Chul Min Ahn1, Min Kwang Byun4.   

Abstract

OBJECTIVE: The study objective was to evaluate the clinical outcomes of surgical decortication as the first line of treatment for pleural empyema.
METHODS: We analyzed the medical records of 111 patients who presented with empyema and were treated with simple drainage or surgical decortication as the first line of treatment at Gangnam Severance Hospital, a tertiary referral medical center in Seoul, Korea.
RESULTS: Of 111 patients with empyema, 27 underwent surgical decortication as the first intervention. Surgical decortication showed a better treatment success rate in all study subjects (96.3%, 26/27 patients) compared with simple drainage (58.3%, 49/84 patients; P < .0001 for method comparison). After propensity-scored matching, decortication resulted in a better outcome (95.0%, 19/20 patients) versus drainage (56.7%, 17/30 patients; P = .003). Surgical decortication as the first line of treatment for empyema was the best predictor of treatment success after adjustment for compounding factors (odds ratio, 14.529; 95% confidence interval, 1.715-123.074; P = .014).
CONCLUSIONS: The first treatment choice for pleural empyema is a critical determinant of ultimate therapeutic success. After adjusting for confounding variables, surgical decortication is the optimal first treatment choice for advanced empyema.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22929218     DOI: 10.1016/j.jtcvs.2012.07.035

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Counterpoint: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? No.

Authors:  Gene L Colice; Steven Idell
Journal:  Chest       Date:  2014-01       Impact factor: 9.410

2.  A simple weighted scoring system to guide surgical decision-making in patients with parapneumonic pleural effusion.

Authors:  Che-Chia Chang; Tzu-Ping Chen; Chi-Hsiao Yeh; Pin-Fu Huang; Yao-Chang Wang; Shun-Ying Yin
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Assessment of the usefulness of video-assisted thoracoscopic surgery in patients with non-tuberculous thoracic empyema.

Authors:  Heesung Lee; Sangmyeon Park; Hoseung Shin; Kunil Kim
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 4.  Infectious pleural effusion status and treatment progress.

Authors:  Wei Yang; Bo Zhang; Ze-Ming Zhang
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

5.  Pleural Empyema Following Liver Resection: A Rare But Serious Complication.

Authors:  Claire Goumard; David Fuks; François Cauchy; Jacques Belghiti; Catherine Paugam-Burtz; Yves Castier; Olivier Soubrane
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

6.  Modified single-port non-intubated video-assisted thoracoscopic decortication in high-risk parapneumonic empyema patients.

Authors:  Chen-Hao Hsiao; Ke-Cheng Chen; Jin-Shing Chen
Journal:  Surg Endosc       Date:  2016-08-12       Impact factor: 4.584

7.  Surgical outcome of empyema thoracis patients with special correlation to pre-operative contrast-enhanced computerized tomography (CECT) thorax morphometry.

Authors:  Narendra Nath Das; Siddharth Lakhotia; Ashish Verma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-10-15

Review 8.  Pleural infection and empyema.

Authors:  Yong Soo Kwon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-04-25

9.  Is open decortication superior to fibrinolytic therapy as a first line treatment in the management of pleural empyema?

Authors:  Sultan Ahmed; Hammad Azam; Imran Basheer
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

10.  Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.

Authors:  Jason R McClune; Candice L Wilshire; Jed A Gorden; Brian E Louie; Alexander S Farviar; Michael J Stefanski; Eric Vallieres; Ralph W Aye; Christopher R Gilbert
Journal:  Can Respir J       Date:  2016-06-30       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.